# Patient-Controlled Sedation in Port Implantation (PACSPI-2)

> **NCT05688384** · PHASE4 · COMPLETED · sponsor: **Region Jönköping County** · enrollment: 340 (actual)

## Conditions studied

- Pain
- Patient Satisfaction
- Cancer
- Venous Puncture

## Interventions

- **DRUG:** Propofol + Alfentanil

## Key facts

- **NCT ID:** NCT05688384
- **Lead sponsor:** Region Jönköping County
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-19
- **Primary completion:** 2024-11-08
- **Final completion:** 2024-11-08
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05688384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05688384, "Patient-Controlled Sedation in Port Implantation (PACSPI-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05688384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*